Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Anticancer Research|April 13, 2016
Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell ApplicationJakub Fichtl, Vladislav Treska, Daniel Lysak, et al.
Hepato-Gastroenterology|February 23, 2012
Prognostic value of the number and volume of liver tumours on portal vein embolization outcomesVladislav Treska, Tomas Skalicky, Vaclav Liska, et al.
Frontiers in Oncology|February 16, 2023
Unicentric form of Castleman´s disease, pitfalls of diagnosis and surgical treatmentJiri Molacek, Vladislav Treska, Tomas Skalicky, et al.
Scientific Reports|October 26, 2016
Two flagellar BAR domain proteins in Trypanosoma brucei with stage-specific regulationZdenka Cicova, Mario Dejung, Tomas Skalicky, et al.
RNA (New York, N.Y.)|October 3, 2022
HITS-CLIP analysis of human ALKBH8 reveals interactions with fully processed substrate tRNAs and with specific noncoding RNAsIvana Cavallin, Marek Bartosovic, Tomas Skalicky, et al.
International Journal of Oncology|April 16, 2016
Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapyDavid Smid, Vlastimil Kulda, Kristyna Srbecka, et al.
Anticancer Research|April 5, 2017
Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot StudyVaclav Liska, Vladislav Treska, Tomas Skalicky, et al.
In Vivo (Athens, Greece)|September 3, 2020
Long-term Results of Surgery for Colorectal Liver Metastases in Terms of Primary Tumour Location and Clinical Risk FactorsVladislav Treska, Martin Skala, Kristyna Prochazkova, et al.
Anticancer Research|September 9, 2018
Portal Vein Embolization (PVE) <i>Versus</i> PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver MetastasesVladislav Treska, Jakub Fichtl, Jaroslav Ludvik, et al.
In Vivo (Athens, Greece)|April 28, 2022
Bevacizumab Does Not Inhibit the Formation of Liver Vessels and Liver Regeneration Following Major Hepatectomy: A Large Animal Model StudyOndrej Troup, Adam Skalicky, Lucie Vistejnova, et al.
Pageof 3